HUB

Immunotherapy helps Navy veteran beat stage 4 lung cancer

It started with a bit of blood. In April 2013, then 68-year-old John Ryan checked in with his primary care physician after he suddenly began to cough up trace amounts of blood. One emergency room trip ...
ascopubs.org

Olink proteomics analysis to identify biomarkers of radiation- and immunotherapy-induced pneumonitis.

Prospective observational study to evaluate efficacy and safety of immunotherapy (IO) in elderly (eld) patients (pts) with non-small cell lung cancer (NSCLC) undergoing comprehensive geriatric ...
Healio

Standard corticosteroids ‘established’ as proper therapy for immune-related pneumonitis

Please provide your email address to receive an email when new articles are posted on . A 6-week corticosteroids regimen significantly improved treatment success for immune-related pneumonitis ...
Healio

Real-world analysis supports ‘obesity paradox’ after immunotherapy for solid tumors

Please provide your email address to receive an email when new articles are posted on . An analysis of two matched cohorts found improved 1-year survival among those with higher BMI. Those with higher ...
Morningstar

DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not ...

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for DATROWAY®(datopotamab deruxtecan-dlnk) has been accepted and granted Priority Review in the US for the treatment ...